Effects of Aspirin and Other Nonsteroidal Anti-Inflammatory Drugs on Biofilms and Planktonic Cells of Candida albicans

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 1, 2004, Pages 41-47

  Alem, Mohammed A S ^a   Douglas, L Julia ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; DICLOFENAC; ETODOLAC; IBUPROFEN; MELOXICAM; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIOFILM; CANDIDA ALBICANS; CELL SURVIVAL; CELL ULTRASTRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; FUNGUS HYPHAE; INTERMETHOD COMPARISON; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BIOFILMS; CANDIDA ALBICANS; CULTURE MEDIA; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0346732026     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.1.41-47.2004     Document Type: Article

References (35)

1. Aumercier, M., D. M. Murray, and J. L. Rosner. 1990. Potentiation of susceptibility to aminoglycosides by salicylate in Escherichia coli. Antimicrob. Agents Chemother. 34:786-791.
2. Bachmann, S. P., K. VandeWalle, G. Ramage, T. F. Patterson, B. L. Wickes, J. R. Graybill, and J. L. Lopez-Rlbot. 2002. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob. Agents Chemother. 46:3591-3596.
3. Baillie, G. S., and L. J. Douglas. 1998. Iron-limited biofilms of Candida albicans and their susceptibility to amphotericin B. Antimicrob. Agents Chemother. 42:2146-2149.
4. Baillie, G. S., and L. J. Douglas. 1999. Candida biofilms and their susceptibility to antifungal agents. Methods Enzymol. 310:644-656.
5. Baillie, G. S., and L. J. Douglas. 1999. Role of dimorphism in the development of Candida albicans biofilms. J. Med. Microbiol. 48:671-679.
6. Chandra, J., P. K. Mukherjee, S. D. Leidich, F. F. Faddoul, L. L. Hoyer, L. J. Douglas, and M. A. Ghannoum. 2001. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J. Dent. Res. 80:903-908.
7. Dannhardt, G., and W. Kiefer. 2001. Cyclooxygenase inhibitors-current status and future prospects. Eur. J. Med. Chem. 36:109-126.
8. Deva, R., R. Ciccoli, T. Schewe, J. L. F. Kock, and S. Nigam. 2000. Arachidonic acid stimulates cell growth and forms a novel oxygenated metabolite in Candida albicans. Biochim. Biophys. Acta 1486:299-311.
9. Deva, R., R. Ciccoli, L. Kock, and S. Nigam. 2001. Involvement of aspirin-sensitive oxylipins in vulvovaginal candidiasis. FEMS Microbiol. Lett. 198: 37-43.
10. Douglas, L. J. 2003. Candida biofilms and their role in infection. Trends Microbiol. 11:30-36.
11. Farber, B. F., and A. G. Wolff. 1992. The use of nonsteroidal antiinflammatory drugs to prevent adherence of Staphylococcus epidermidis to medical polymers. J. Infect. Dis. 166:861-865.
12. Farber, B. F., H. C. Hsieh, E. D. Donnenfeld, H. D. Perry, A. Epstein, and A. Wolff. 1995. A novel antibiofilm technology for contact lens solutions. Ophthalmology 102:831-836.
13. Gilbert, P., T. Maira-Litran, A. J. McBain, A. H. Rickard, and F. W. Whyte. 2002. The physiology and collective recalcitrance of microbial biofilm communities. Adv. Microb. Physiol. 46:203-256.
14. Harris, S. G., J. Padilla, L. Koumas, D. Ray, and R. P. Phipps. 2002. Prostaglandins as modulators of immunity. Trends Immunol. 23:144-150.
15. Hawser, S. P., and L. J. Douglas. 1994. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect. Immun. 62:915-921.
16. Hawser, S. P., and L. J. Douglas. 1995. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob. Agents Chemother. 39: 2128-2131.
17. Hornby, J. M., E. C. Jensen, A. D. Lisec, J. J. Tasto, B. Jahnke, R. Shoemaker, P. Dussault, and K. W. Nickerson. 2001. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl. Environ. Microbiol. 67:2982-2992.
18. 2 enhances and gamma interferon inhibits germ tube formation in Candida albicans. Infect. Immun. 58:260-262.
19. Kuhn, D. M., T. George, J. Chandra, P. K. Mukherjee, and M. A. Ghannoum. 2002. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 46:1773-1780.
20. Mah, T.-F. C., and G. A. O'Toole. 2001. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 9:34-39.
21. Muller, E., J. Al-Attar, A. G. Wolff, and B. F. Farber. 1998. Mechanism of salicylate-mediated inhibition of biofilm in Staphylococcus epidermidis. J. Infect. Dis. 177:501-503.
22. Noverr, M. C., J. R. Erb-Downward, and G. B. Huffnagle. 2003. Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes. Clin. Microbiol. Rev. 16:517-533.
23. Noverr, M. C., S. M. Phare, G. B. Toews, M. J. Coffey, and G. B. Huffnagle. 2001. Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect. Immun. 69:2957-2963.
24. Noverr, M. C., G. B. Toews, and G. B. Huffnagle. 2002. Production of prostaglandins and leukotrienes by pathogenic fungi. Infect. Immun. 70:400-402.
25. Pina-Vaz, C., F. Sansonetty, A. G. Rodrigues, J. Martinez-De-Oliveira, A. F. Fonseca, and P.-A. Mardh. 2000. Antifungal activity of ibuprofen alone and in combination with fluconazole against Candida species. J. Med. Microbiol. 49:831-840.
26. Price, C. T. D., I. R. Lee, and J. E. Gustafson. 2000. The effects of salicylate on bacteria. Int. J. Biochem. Cell Biol. 32:1029-1043.
27. Ramage, G., K. VandeWalle, B. L. Wickes, and J. L. Lopez-Ribot. 2001. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 45:2475-2479.
28. Ramage, G., K. VandeWalle, B. L. Wickes, and J. L. Lopez-Ribot. 2001. Biofilm formation by Candida dubliniensis. J. Clin. Microbiol. 39:3234-3240.
29. Ramage, G., S. P. Saville, B. L. Wickes, and J. L. Lopez-Ribot. 2002. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl. Environ. Microbiol. 68:5459-5463.
30. Ramage, G., K. VandeWalle, S. P. Bachmann, B. L. Wickes, and J. L. Lopez-Ribot. 2002. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob. Agents Chemother. 46:3634-3636.
31. Rosner, J. L. 1985. Nonheritable resistance to chloamphenicol and other antibiotics induced by salicylates and other chemotactic repellents in Escherichia coli K-12. Proc. Natl. Acad. Sci. USA 82:8771-8774.
32. Scott, E. M., V. N. Tariq, and R. M. McCrory. 1995. Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitro. Antimicrob. Agents Chemother. 39:2610-2614.
33. Witken, S. S., J. Jeremias, and W. J. Ledger. 1988. A localized vaginal allergic response in women with recurrent vaginitis. J. Allergy Clin. Immunol. 81:412-416.
34. Wu, K. K. 2000. Aspirin and salicylate. An old remedy with a new twist. Circulation 102:2022-2023.
35. Xu, X.-M., L. Sansores-Garcia, X.-M. Chen, N. Matijevic-Aleksic, M. Du, and K. K. Wu. 1999. Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. Proc. Natl. Acad. Sci. USA 96: 5292-5297.